| Literature DB >> 29317643 |
Yi Zhang1, Jing Li2, Zhuo Ma1, Chao Shan1, Xiwu Gao3.
Abstract
Two unique housefly strains, MSS and N-MRS, were selected and used to clarify mechanisms of sex-associated malathion resistance in the housefly, Musca domestica. Compared with the lab-susceptible CSS strain, susceptible females and resistant males were observed in the malathion-susceptible MSS strain, while the malathion-resistant near-isogenic line, N-MRS, achieved similar resistance level between genders. Significant synergistic effect of the esterase-inhibitor DEF on resistant houseflies pointed to the important involvement of esterase in this specific malathion resistance. Examination of the carboxylesterase gene MdαE7 in malathion resistant housefly populations found seven, non-synonymous SNP mutations (Ser250-Thr, Trp251-Ser, Met303-Ile, Leu354-Phe, Ser357-Leu, Trp378-Arg and Ser383-Thr), not found in susceptible houseflies, revealing a strong correlation between these mutations and the development of malathion resistance. Further genetic analysis conducted with bioassays by topical application and nucleotide polymorphism detection provided a first line of molecular evidence for a linkage between a male-determining factor and MdαE7 gene in the MSS and N-MRS males. This linkage results in a much higher level of malathion resistance for males than females in the MSS strain. Lastly, quantitative real-time PCR showed that MdαE7 was over expressed in the resistant strain due to the increased transcription level of mRNA rather than gene duplication.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29317643 PMCID: PMC5760516 DOI: 10.1038/s41598-017-17325-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Synergism of DEF on malathion toxicity in the MSS and N-MRS strains.
| Strain | Na | Slope (SE) | LD50 (FL 95%) μg/fly | χ2 (df)b | RRc | SRd |
|---|---|---|---|---|---|---|
|
| ||||||
| CSS | 289 | 1.1 (0.22) | 9.21 (6.29–13.9) | 0.61 (4) | 1.0 | |
| MSS | 355 | 4.1 (0.80) | 0.829 (0.713–0.974) | 1.6 (3) | 0.090 | |
| MSS + DEF | 320 | 6.1 (0.84) | 0.445 (0.376–0.508) | 5.1 (3) | 1.86 | |
| N-MRS | 316 | 5.2 (0.70) | 518 (470–569) | 8.8 (4) | 56 | |
| N-MRS + DEF | 281 | 3.4 (0.39) | 1.76 (1.54–2.05) | 2.0 (4) | 294 | |
|
| ||||||
| CSS | 270 | 1.7 (0.27) | 11.6 (7.38–17.6) | 1.6 (3) | 1.0 | |
| MSS | 412 | 4.8 (0.42) | 119 (104–133) | 2.0 (3) | 10 | |
| MSS + DEF | 360 | 7.7 (1.8) | 0.677 (0.546–0.749) | 6.6 (4) | 176 | |
| N-MRS | 400 | 6.9 (0.66) | 632 (585–681) | 6.3 (4) | 54 | |
| N-MRS + DEF | 310 | 1.4 (0.20) | 4.96 (3.61–7.59) | 9.1 (4) | 127 | |
aNumber of houseflies used in the bioassay. bChi-square value and degrees of freedom (df) as calculated by PoloPlus. cRR = LD50 of malathion/LD50 of malathion for CSS strain with corresponding genders. dSR = LD50 of malathion/LD50 of malathion + DEF.
Non-synonymous mutations in malathion resistant houseflya.
| Nucleotide | Amino acid | ||
|---|---|---|---|
| Site | Substitutionb | Site | Substitutionb |
| 748 | T → A | 250 | Ser → Thr |
| 752 | G → C | 251 | Trp → Ser |
| 909 | G → A | 303 | Met → Ile |
| 1060 | C → T | 354 | Leu → Phe |
| 1070 | C → T | 357 | Ser → Leu |
| 1132 | T → C | 378 | Trp → Arg |
| 1148 | G → C | 383 | Ser → Thr |
| 1149 | T → A | ||
aMutations are generated by the corresponding nucleotide substitutions displayed in the same row. bThe former nucleotide or amino acid was detected in susceptible housefly and the latter in resistant housefly.
Figure 1The structure of the active cavity of MdαE7. The catalytic triad and oxyanion hole are colored magenta and blue, respectively. The substrate binding pocket is divided into a small pocket and a large pocket, colored green and yellow, respectively. Mutations are displayed as sticks and colored dark red, except Trp251 and Leu354, which are located in the binding pocket.
Distribution of polymorphic alleles of non-synonymous mutations in the MdαE7.
| Population | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MSS−♀ | MSS−♂ | N-MRS- ♀ | N-MRS− ♂ | BC− ♀ | BC− ♂ | F2− ♀b | F2− ♂b | |||
| Frequency of Polymorphisms of Amino Acid Mutation Sites (%, ± SE)a | S250T | T/T | 97.5 ± 2.5 | 1.25 ± 1.25 | 0 | 0 | 100 | 1.25 ± 1.25 | 58.14 ± 1.76 | 0 |
| T/A | 2.5 ± 2.5 | 98.75 ± 1.25 | 0 | 6.25 ± 3.75 | 0 | 98.75 ± 1.25 | 41.86 ± 1.76 | 51.72 ± 2.68 | ||
| A/A | 0 | 0 | 100 | 93.75 ± 3.75 | 0 | 0 | 0 | 48.28 ± 2.68 | ||
| W251S | G/G | 98.75 ± 1.25 | 2.5 ± 1.44 | 0 | 0 | 100 | 1.25 ± 1.25 | 58.18 ± 2.05 | 0 | |
| G/C | 1.25 ± 1.25 | 97.5 ± 1.44 | 0 | 0 | 0 | 98.75 ± 1.25 | 41.82 ± 2.05 | 50.99 ± 2.60 | ||
| C/C | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
| M303I | G/G | 100 | 20 ± 4.08 | 0 | 0 | 100 | 6.25 ± 3.75 | 58.46 ± 1.64 | 0 | |
| G/A | 0 | 80 ± 4.08 | 8.75 ± 4.27 | 5 ± 2.89 | 0 | 93.75 ± 3.75 | 41.54 ± 1.64 | 50.99 ± 2.60 | ||
| A/A | 0 | 0 | 91.25 ± 4.27 | 95 ± 2.89 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
| L354F | C/C | 98.75 ± 1.25 | 12.5 ± 3.23 | 0 | 0 | 100 | 3.75 ± 3.75 | 58.50 ± 1.88 | 0 | |
| C/T | 1.25 ± 1.25 | 87.5 ± 3.23 | 11.25 ± 2.39 | 5 ± 2.89 | 0 | 96.25 ± 3.75 | 41.50 ± 1.88 | 50.99 ± 2.60 | ||
| T/T | 0 | 0 | 88.75 ± 2.39 | 95 ± 2.89 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
| S357L | C/C | 100 | 12.5 ± 4.79 | 0 | 0 | 100 | 11.25 ± 7.18 | 59.55 ± 2.14 | 0 | |
| C/T | 0 | 87.5 ± 4.79 | 13.75 ± 2.39 | 6.25 ± 3.75 | 0 | 88.75 ± 7.18 | 40.45 ± 2.14 | 51.72 ± 2.68 | ||
| T/T | 0 | 0 | 86.25 ± 2.39 | 93.75 ± 3.75 | 0 | 0 | 0 | 48.28 ± 2.68 | ||
| W378R | T/T | 96.25 ± 2.39 | 1.25 ± 1.25 | 0 | 0 | 100 | 0 | 56.72 ± 1.71 | 0 | |
| T/C | 3.75 ± 2.39 | 98.75 ± 1.25 | 3.75 ± 2.39 | 2.5 ± 1.44 | 0 | 100 | 43.28 ± 1.71 | 50.99 ± 2.60 | ||
| C/C | 0 | 0 | 96.25 ± 2.39 | 97.5 ± 1.44 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
| G/G | 96.25 ± 2.39 | 1.25 ± 1.25 | 0 | 0 | 100 | 0 | 58.14 ± 1.76 | 0 | ||
| S383T | G/C | 3.75 ± 2.39 | 98.75 ± 1.25 | 3.75 ± 2.39 | 5 ± 2.89 | 0 | 100 | 41.86 ± 1.76 | 50.99 ± 2.60 | |
| C/C | 0 | 0 | 96.25 ± 2.39 | 95 ± 2.89 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
| T/T | 100 | 7.5 ± 3.23 | 0 | 0 | 100 | 6.25 ± 3.75 | 58.83 ± 1.75 | 0 | ||
| T/A | 0 | 92.5 ± 3.23 | 3.75 ± 2.39 | 2.5 ± 1.44 | 0 | 93.75 ± 3.75 | 41.17 ± 1.75 | 50.99 ± 2.60 | ||
| A/A | 0 | 0 | 96.25 ± 2.39 | 97.5 ± 1.44 | 0 | 0 | 0 | 49.01 ± 2.60 | ||
aValues represent mean ± SE for four replications of frequency (%) analyses of each mutation; the nucleotide polymorphisms are underlined. bData was synthesized from the four malathion-treated groups in corresponding gender.
Malathion treatment of females and males in F2 generation.
| Malathion Treatmentsa | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Population | LD10 Treatment | LD50 Treatment | LD90 Treatment | |||||||||
| Nb | LD10 μg/flyc | NA (Proportion)d | Group A (collected dead houseflies) | LD50 μg/flyc | NB (Proportion)d | Group B(collected dead houseflies) | LD90 μg/flyc | NC (Proportion)d | Group C (collected dead houseflies) | ND (Proportion)d | Group D (collected alive houseflies) | |
| F2♀ | 1858 | 1.27 | 315 (0.17) | F2♀- < LD10 | 33.47 | 566 (0.30) | F2♀-LD10–50 | 880.46 | 934 (0.50) | F2♀-LD50–90 | 43 (0.02) | F2♀- > LD90 |
| F2♂ | 1748 | 216.92 | 65 (0.04) | F2♂- < LD10 | 396.2 | 735 (0.42) | F2♂-LD10–50 | 723.81 | 917 (0.52) | F2♂-LD50–90 | 31 (0.02) | F2♂- > LD90 |
aEach treatment was performed 4 times. bNumber of houseflies used in LD10 treatment. cThe doses of malathion administered to these houseflies are chosen according to the toxicity analysis in the F2 generation (Table 5). dNumber of collected houseflies in each group with corresponding letter (Proportion = collected individuals of each group/ individuals used in LD10 treatment).
Figure 2SNP mutation allele frequency distribution for each F2 generation housefly group, distinguished by gender and level of malathion tolerance. The frequency of allele expression shown along the Y axis is the percentage of houseflies carrying the corresponding homozygous or heterozygous allele(s). Housefly groups are shown along the X axis; A1, B1, C1 and D1 represent the groups in F2 females that were dead under LD10, between LD10 and LD50, between LD50 and LD90 and alive above LD90 dosage treatment, respectively; and A2, B2, C2 and D2 represent the groups in F2 males that were dead under LD10, between LD10 and LD50, between LD50 and LD90 and alive above LD90 dosage treatment, respectively. Error bars represent standard errors of the means (n = 4 independent replicates of treatment).
Malathion toxicity in the F1, F2, and BC generations.
| Strain | Na | Slope (SE) | LD50 (FL 95%) μg/fly | χ2 (df)b | RRc |
|---|---|---|---|---|---|
|
| |||||
| F1 (MSS♀ × N-MRS♂) | 359 | 7.4 (0.83) | 360 (331–384) | 1.2 (3) | 39 |
| F2 (F1♀ × F1♂) | 350 | 0.93 (0.12) | 25.2 (14.6–40.7) | 2.7 (3) | 2.7 |
| BC (MSS♀ × F1♂) | 283 | 2.0 (0.36) | 1.62 (1.23–2.47) | 2.3 (3) | 0.18 |
|
| |||||
| F1 (MSS♀ × N-MRS♂) | 343 | 5.5 (0.67) | 466 (410–514) | 8.3 (4) | 40 |
| F2 (F1♀ × F1♂) | 326 | 4.7 (0.68) | 415 (364–479) | 0.98 (3) | 36 |
| BC (MSS♀ × F1♂) | 314 | 5.7 (1.0) | 413 (353–469) | 1.9 (3) | 36 |
aNumber of houseflies used in the bioassay. bChi-square value and degrees of freedom (df) as calculated by PoloPlus. cRR = LD50 of malathion/ LD50 of malathion for CSS strain of corresponding gender (Table 1).
Figure 3Illustration of genetic crosses with corresponding genotypes and theoretical segregation ratios. (A) Cross of N-MRS males with MSS females and subsequent self-cross of the F1 hybrids. (B) Backcross of F1 males with MSS females. *Refer to text for explanation of theoretical segregation ratios.
Relative expression of MdαE7 gene in the MSS and N-MRS strains.
| Strain |
| p-value between MSS and N-MRS (2-tailed) | p-value between genders (2-tailed) | |||
|---|---|---|---|---|---|---|
| DNA | mRNA | DNA | mRNA | DNA | mRNA | |
|
| ||||||
| MSS | 4.25 ± 0.751 | 0.164 ± 0.0269 | 0.164 |
| 0.115 | 0.590 |
| N-MRS | 6.26 ± 1.08 | 1.23 ± 0.265 | 0.164 |
| 0.084 | 0.132 |
|
| ||||||
| MSS | 6.27 ± 0.827 | 0.186 ± 0.0294 | 0.057 |
| 0.115 | 0.590 |
| N-MRS | 8.34 ± 0.404 | 2.53 ± 0.863 | 0.057 |
| 0.084 | 0.132 |
p-values for all two-sample comparisons were obtained by a Student’s t-test. Significant p-values (α < 0.05) are underlined.